instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: The overall number of religious exemptions in the state climbed by 25%, from the 2017-18 school year to the 2018-19 school year, according to the state’s Department of Public Health. The agency said the increase from 2% of students to 2.5% represents the largest single year upturn in religious exemptions for vaccinations since it began tracking statewide data 10 years ago. While the immunization rate for kindergarten students remains high in Connecticut, the new information shows it has declined from 96.5% to 95.9%. “It does raise concern,” said Public Health Commissioner Renee D. Coleman-Mitchell, adding how the new numbers warrant releasing more data, including county-by-county and school-by-school. The commissioner originally planned not to release the school-by-school data, but Democratic Gov. Ned Lamont on Wednesday overruled that decision, arguing the public should have the information. A Bristol couple on Thursday asked a court to stop the release of the school-by-school vaccination rates, arguing they’ll suffer “irreparable harm” if the information is released. Their unvaccinated son attends a private school where 18% of the students claimed a religious exemption from vaccinations, according to school-by-school data DPH released in May. The couple has another lawsuit pending. “We believe that out of deference and respect for the authority of the court, no new data should be released during the pendency of this litigation,” the couple said in a written statement. “To do otherwise is to move into the dangerous waters of undermining the separation of powers that is so important to our system of government.” Lamont’s office declined to comment on the pending litigation. Coleman-Mitchell said the resurgence of measles in the U.S. is of great concern and the decline in Connecticut’s vaccination rates, coupled with the increase in religious exemptions, validates the need to release both county-by-county and school-by-school data by Oct. 21. There have been three cases so far in Connecticut this year. ___ This story has been corrected to show that the Festas live in Bristol, not Woodstock. Claim: Data show 25% increase in religious exemptions for vaccines.
answer:
New data released Thursday show more Connecticut students are being exempted from vaccinations for measles, mumps and rubella for religious reasons.


question:
Paragraph: "The story covers cost in the very last two lines. Adequate quantification of benefits seen in the study. Story says ""few eye-related complications"" were reported in the Lucentis group, but didn’t say what few means or what they were. We don’t think that’s quite adequate. Adequate job explaining how the study was done and what it means. No disease mongering in the story. One quote from the head of the National Eye Institute. But he didn’t really evaluate evidence – only talked about hope. Meantime, no mention that Genentech funded  the trial (a strength of the NYT story was its discussion of the ""pay for play"" aspect of the research) – and no mention that Dr. Bressler disclosed financial ties to Genentech. From the Times: Some doctors criticized the organizers of the trial for testing Lucentis rather than another Genentech drug, Avastin, which works in the same way as Lucentis. Although it is a cancer drug, Avastin is often used off-label for eye diseases because it is far cheaper than Lucentis, costing only $20 to $100 a dose, compared with $2,000 for Lucentis. Avastin is undercutting sales of Lucentis, which totaled $1.1 billion in the United States last year. Organizers of the trial conceded that a major reason Lucentis was chosen was that Genentech, which is now owned by Roche, agreed to provide the drug free of charge and to contribute $9 million in additional financing — but only if Lucentis were used. “Obviously you can’t underplay $9 million,” said Dr. Ferris of the eye institute, which is part of the part of the National Institutes of Health. But he said there were other factors as well, like a belief that Lucentis might have been the better drug. Dr. Philip J. Rosenfeld, a professor of ophthalmology at the University of Miami, said the decision was “clearly a case of pay to play” since Genentech’s money dictated the choice of drugs. At least the story mentioned the uncertainty about whether Lucentis is any better  than the cheaper Avastin, and mentioned an upcoming trial comparing the two in age-related macular degeneration. The story explains that Lucentis was approved 4 years ago for another cause. Story explains the drug is already approved for another use, and it also – at the very end – mentions that an older and much cheaper drug is also effective. It’s clear the story did not rely on a news release." Claim: Drug Reverses Diabetes-Related Vision Loss
answer:
The key difference between this and the NYT story was that WebMD didn’t reflect on the question of why Genentech didn’t test its cheaper Avastin against the much more expensive Lucentis. The important issue of corporate sponsorship of a clinical trial was overlooked. You want to talk about comparative effectiveness research? This would have been a good place for it.


question:
Paragraph: It is still rare for babies to get syphilis from their infected mothers, but figures released Tuesday show more than 900 cases were reported last year. That’s more than double the number in 2013. Most cases were in the Southeast and Southwest. The last time the number was that high or higher was in the 1990s. In adults, cases of syphilis and other sexually transmitted diseases also are rising. Health officials say possible reasons include a wave of illegal drug use. They say women should be tested during pregnancy so they can be treated with antibiotics Syphilis can deform or kill babies. At least 77 of last year’s cases were stillborn or died. Claim: Newborn syphilis cases in US reach highest level in 20 years.
answer:

The number of U.S. babies born infected with syphilis has reached the highest level in 20 years.